Clicky

KPC Pharmaceuticals Inc(600422)

Description: KPC Pharmaceuticals, Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs in the People's Republic of China and internationally. It offers artemether, panax notoginseng, and gastrodine series drugs, as well as Chinese medicines and ethnic drugs under the Luotai, Tianxuanqing, Artemedine, Artem, and Arco brand names for treating cardio-cerebral-vascular and nervous system diseases, as well as malaria. The company also provides Dai medicines; antibiotics, chemical medicinal raw materials, chemical pharmaceutical preparations, traditional Chinese medicinal materials, biological products, biochemical drugs, and health foods; Amoxicillin, Cefaclor, Alfacalcidol, Artz, Snaplets, and Ribavirin spray products; glycyrrhizic acid; and GLP-1, a long-acting hypoglycemic drug. It markets artemisinin antimalarials, generic drugs, and medical apparatus. The company was formerly known as Kunming Pharmaceutical Corporation and changed its name to KPC Pharmaceuticals, Inc. in April 2015. KPC Pharmaceuticals, Inc. was founded in 1951 and is based in Kunming, the People's Republic of China.


Keywords: Chemical Pharmaceutical Organic Compounds Antibiotics Traditional Chinese Medicine Biological Products Malaria Glp 1 Amoxicillin Oxygen Compounds Ribavirin Kunming Pharmaceutical Corporation Spray Products Artem Chemical Pharmaceutical Preparations

Home Page: www.kpc.com.cn

No.166 Keyi Road
Kunming, 650106
China
Phone: 86 871 6831 9868


Officers

Name Title
Xianggang Zhong Pres
Mr. Lei Wang Chief Financial Officer
Bo Xie VP and Gen. Mang. of the Manufacturing Center
Mr. Jun Wang VP
Xiaoru Wu VP
Shenglong Wu VP
Zhenbo Hu Director and Exec. VP
Zhang Mengxun Company Sec.

Exchange: SHG

Country: CN

Currency: Renminbi (¥)

Forward PE: 0
Trailing PE: 27.7241
Price-to-Book MRQ: 2.2988
Price-to-Sales TTM: 1.351
IPO Date: 2000-11-16
Fiscal Year End: December
Full Time Employees: 0
Back to stocks